Earnings Per Share
EPS (Diluted)
ResMed EPS (Diluted) increased by 2.2% to $2.74 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.5%, from $2.48 to $2.74. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows an upward trend with a 30.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher values indicate stronger profitability even when accounting for potential share dilution.
Detailed definition
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Peer comparison
Used by all public companies to provide a realistic view of earnings per share for investors.
Metric ID:
eps_dilutedHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.33 | $1.39 | $1.37 | $1.22 | $1.32 | $1.43 | $1.53 | $1.58 | $1.55 | $1.49 | $1.42 | $2.04 | $1.97 | $2.11 | $2.34 | $2.48 | $2.58 | $2.37 | $2.68 | $2.74 |
| QoQ Change | — | +4.5% | -1.4% | -10.9% | +8.2% | +8.3% | +7.0% | +3.3% | -1.9% | -3.9% | -4.7% | +43.7% | -3.4% | +7.1% | +10.9% | +6.0% | +4.0% | -8.1% | +13.1% | +2.2% |
| YoY Change | — | — | — | — | -0.8% | +2.9% | +11.7% | +29.5% | +17.4% | +4.2% | -7.2% | +29.1% | +27.1% | +41.6% | +64.8% | +21.6% | +31.0% | +12.3% | +14.5% | +10.5% |
Range$1.22 – $2.74
CAGR+16.4%
Avg YoY Growth+19.4%
Median YoY Growth+16.0%
Current Streak2 quarters growth
EPS (Diluted) at Other Companies
Frequently Asked Questions
- What is ResMed's eps (diluted)?
- ResMed (RMD) reported eps (diluted) of $2.74 in Q1 2026.
- How has ResMed's eps (diluted) changed year-over-year?
- ResMed's eps (diluted) increased by 10.5% year-over-year, from $2.48 to $2.74.
- What is the long-term trend for ResMed's eps (diluted)?
- Over 4 years (2021 to 2025), ResMed's eps (diluted) has grown at a 30.9% compound annual growth rate (CAGR), from $3.24 to $9.51.
- What does eps (diluted) mean?
- Earnings per share calculated as if all potential shares were issued.